It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
In the last week, CBI's quality assurance group has conducted an
extensive review of our administrative and laboratory procedures and
has re-examined our facility for the presence of viable environmental
pathogens. None of these tests has come back positive. Among the
findings of this review:
-- There is no evidence in the BSL3 for the presence of surface
contamination or air-borne contamination.
-- At the time of the sample processing for the Pentagon, no
other anthrax-related work was being done.
-- CBI has no on-going work which requires us to work with
anything but the vegetative form of anthrax.
-- CBI has no on-going programs dealing with anthrax spores.
-- CBI's strict protocols which prohibit analyzing test samples
in the presence of a positive control sample were strictly
adhered to.
-- Video records of the BSL3 lab on the day in question show that
the testing was carried out per the operative protocols, that
the required decontamination procedures of the workspace prior
to working with the sample were followed, and that no gross
deviations in standard procedures occurred.
stockwatch
Originally posted by Duzey
Commonwealth Biotechnologies issued a press release today, they have finished their internal review: